The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone
Psychopharmacology (Berl)
July 2010
https://pubmed.ncbi.nlm.nih.gov/20386884/
Rationale: Prescription opioid abuse has risen dramatically in the United States as clinicians have increased opioid prescribing for alleviation of both acute and chronic pain. Opioid analgesics with decreased risk for abuse are needed.
Saturday morning Q & A (2017 Conference) (LDN, low dose naltrexone)